December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

HEALTHCARE (NY:XLV)

163.91 +1.34 (+0.83%)
Streaming Delayed Price Updated: 1:36 PM EDT, Jul 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about HEALTHCARE

< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
43 44 Next >
News headline image
Leading And Lagging Sectors For January 29, 2025 ↗
 
Via Benzinga
News headline image
Does China AI Threaten US Tech Dominance? ↗
Anxiety about the competitive threat from Chinese artificial intelligence lab DeepSeek triggered a sharp selloff in US equities on Monday, with the worst of the decline centered in tech. 
Via Talk Markets
Topics Artificial Intelligence ETFs
News headline image
Leading And Lagging Sectors For January 28, 2025 ↗
 
Via Benzinga
News headline image
Biotech And Healthcare Stocks Poised For Gains Ahead ↗
The XLV bounced off the bottom this month up 4% to the $144 level led by biopharma and medtech. 
Via Talk Markets
Topics ETFs Stocks / Equities
News headline image
Leading And Lagging Sectors For January 27, 2025 ↗
 
Via Benzinga
News headline image
Moderna Retains Retail Support With European COVID-19 Vaccine Tender Win, Stock Hits 2-Week High ↗
The agreement, which spans up to four years, allows 17 participating countries access to Moderna’s vaccine in various formats. 
Via Stocktwits
News headline image
Leading And Lagging Sectors For January 24, 2025 ↗
 
Via Benzinga
News headline image
Elevance Health Stock Rises On Upbeat Q4 Revenue, Dividend Boost: Retail's Over The Moon ↗
The firm’s medical-loss ratio (MLR) rose to 92.4% due to Medicaid-related costs but was better than expected. 
Via Stocktwits
News headline image
Leading And Lagging Sectors For January 23, 2025 ↗
 
Via Benzinga
News headline image
J&J Stock Dips As 2025 Sales Guidance Misses Estimate, But Retail Mood Resilient ↗
During the earnings call, J&J highlighted several growth drivers, including its positioning for 5%-7% annual growth through 2030 and plans to increase its dividend annually. 
Via Stocktwits
Topics Earnings
News headline image
Leading And Lagging Sectors For January 22, 2025 ↗
 
Via Benzinga
News headline image
Small Caps Soar, Apple Slips, Treasury Yields Fall On Trump Day 2: What's Driving Markets Tuesday? ↗
Wall Street saw a strong preference for small and mid-cap equities, with the Russell 2000 index leading the market as investors bet on more domestic-friendly policies following Donald Trump's... 
Via Benzinga
Topics Government
News headline image
Moderna Stock Jumps On $590M US Award For Bird Flu Vaccine Development, But Retail Doubts Longevity Under Trump ↗
In 2023, Moderna initiated a Phase 1/2 study to assess the safety and immunogenicity of its investigational bird flu vaccine, mRNA-1018, in healthy adults aged 18 and older. 
Via Stocktwits
News headline image
Leading And Lagging Sectors For January 21, 2025 ↗
 
Via Benzinga
News headline image
Leading And Lagging Sectors For January 20, 2025 ↗
 
Via Benzinga
News headline image
ETFs In Focus Post UnitedHealth's Mixed Q4 Results ↗
UnitedHealth Group, the largest U.S. health insurer, reported mixed fourth-quarter 2024 results. Shares of the stock dropped nearly 6% on the day following the results. This put various ETFs in the... 
Via Talk Markets
Topics ETFs Stocks / Equities
News headline image
Wall Street Roars Ahead Of Trump's Inauguration, Intel Rallies, Bitcoin Tops $105,000: What's Driving Markets Friday? ↗
Risk appetite surged on Wall Street at the end of the week, with investors ramping up stock purchases ahead of Monday's market closure for Martin Luther King Day, which is also when Donald Trump will... 
Via Benzinga
Topics Government
News headline image
Stocks Pause, Chipmakers Rise, Gold Hits 2-Month Highs: What's Driving Markets Thursday? ↗
Wall Street paused for a breather on Thursday, following Wednesday's big rally sparked by a softer-than-predicted December inflation report that fueled speculation on the Federal Reserve delivering... 
Via Benzinga
Topics Economy
News headline image
UnitedHealth's Q4 Revenue Miss Depresses Stock Price And Retail Sentiment Alike ↗
The company's full-year medical loss ratio, a key metric tracking the percentage of premiums paid out for medical expenses, rose to 85.5% from 83.2% in 2023. 
Via Stocktwits
News headline image
Leading And Lagging Sectors For January 16, 2025 ↗
 
Via Benzinga
News headline image
Intuitive Surgical Stock Hits All-Time High After Prelim Q4 Results Outpace Expectations: Retail Goes All In ↗
Intuitive said worldwide da Vinci procedure volumes grew 18% in Q4 and 17% in 2024, driven by U.S. general surgery and international cancer procedures. 
Via Stocktwits
News headline image
Wall Street Rallies As Treasury Yields Fall, Banks Smash Q4 Earnings, Oil Hits $80: What's Driving Markets Wednesday? ↗
Wall Street staged a strong rebound on Wednesday, as mixed inflation data bolstered investor confidence in the Federal Reserve's continuation of easing cycle in 2025, easing recent market anxieties. 
Via Benzinga
Topics Economy
News headline image
Eli Lilly Gets Wall Street Backing After Tuesday’s Turmoil, Stock Rises Premarket As Retail Stays Bullish ↗
JPMorgan's Chris Schott reportedly called the stock dip following the Q4 sales miss a buying opportunity. 
Via Stocktwits
Topics Earnings
News headline image
Leading And Lagging Sectors For January 15, 2025 ↗
 
Via Benzinga
News headline image
Stocks Fail To Rise Despite Benign Producer Inflation, 30-Year Treasury Yields Hit 5%, Ely Lilly Tumbles: What's Driving Markets Tuesday? ↗
A cooler-than-expected December producer inflation report failed to ignite lasting gains on Wall Street Tuesday, reflecting lingering concerns about persistently high inflation among investors. 
Via Benzinga
Topics Economy
News headline image
Eli Lilly Stock Faces Worst Day In Nearly 4 Years On Q4 Weight-Loss Drug Sales Miss, But Retail Bullish On 2025 Projections ↗
The pharma giant expects continued growth for Mounjaro and Zepbound this year, supported by expanded manufacturing capacity and new market launches. 
Via Stocktwits
Topics Earnings
News headline image
We’re In A Bullish Correction ↗
Over the past month, we’ve seen two downtrodden sectors - energy and healthcare - emerge as leaders. But in the grand scheme of things, not much has changed when it comes to the bull market. 
Via Talk Markets
Topics Stocks / Equities
News headline image
Stocks Edge Down Ahead Of Key Inflation Reports, Crude Hits 5-Month High, Bitcoin Sinks: What's Driving Markets Monday? ↗
Traders adopted a cautious approach on Monday as they awaited two critical inflation reports due later this week, seeking clarity on Federal Reserve interest rate policy. 
Via Benzinga
Topics Economy
News headline image
Moderna Stock Sinks To Over 5-Year Low On $1B Sales Guidance Cut: Retail’s Shaken ↗
The revised projection largely reflects declining COVID-19 vaccine demand, as fewer people seek boosters amid the ongoing shift to an endemic phase. 
Via Stocktwits
News headline image
Leading And Lagging Sectors For January 13, 2025 ↗
 
Via Benzinga
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
43 44 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.